{"id":32857,"date":"2026-03-13T12:03:09","date_gmt":"2026-03-13T16:03:09","guid":{"rendered":"https:\/\/vet.purdue.edu\/news\/?p=32857"},"modified":"2026-03-13T12:03:10","modified_gmt":"2026-03-13T16:03:10","slug":"fourth-purdue-amr-conference-promotes-collaboration-to-address-global-health-threat-of-antimicrobial-resistance-through-pvms-one-health-initiative","status":"publish","type":"post","link":"https:\/\/vet.purdue.edu\/news\/fourth-purdue-amr-conference-promotes-collaboration-to-address-global-health-threat-of-antimicrobial-resistance-through-pvms-one-health-initiative.php","title":{"rendered":"Fourth Purdue AMR Conference Promotes Collaboration to Address Global Health Threat of Antimicrobial Resistance through PVM\u2019s One Health Initiative.\u00a0"},"content":{"rendered":"\n

Purdue University served as the place where local, national and international experts came together in-person and online recently for concentrated sharing of research, expertise and insight targeting the threat of multi-drug-resistant infections. The fourth annual AMR Conference February 25-26, 2026, held in Stewart Center, attracted more than 100 attendees from across the U.S. and six other countries.<\/p>\n\n\n\n

The program was designed around three core segments \u2013 Determinants, Dynamics and Deterrence of Drug Resistance \u2013 with each segment featuring an invited external keynote presentation followed by shorter talks given by three Purdue University researchers with relevant expertise. Each segment concluded with a question-and-answer session featuring a panel consisting of all the speakers for that theme. The program aligns with the Purdue One Health Strategic Initiative that focuses on tackling complex challenges with real-world impact at the intersection of human, animal and plant health.<\/p>\n\n\n\n

After opening remarks by Purdue University College of Veterinary Medicine Dean Bret Marsh, DVM, the first segment began with a keynote by Renee Fleeman, PhD, entitled, \u201cDeterminants: The Elements and Mechanisms of AMR.\u201d  Dr. Fleeman is an assistant professor at the University of Central Florida\u2019s College of Medicine, where she serves on the faculty of the Burnett School of Biomedical Sciences.  Her research focuses on elucidating the mechanisms bacteria utilize to resist antimicrobials to provide insight for developing novel therapeutics. <\/p>\n\n\n

\n
\"Three
AMR Conference keynote speakers (left-right) Dr. Dubraska D\u00edaz-Campos, Dr. Herman Barkema, and Dr. Renee Fleeman.<\/figcaption><\/figure>\n<\/div>\n\n\n

Dr. Fleeman received her Ph.D. from the University of South Florida in 2017. Then, as a post-doctoral researcher at the University of Texas at Austin, she was awarded the prestigious NIH Pathway to Independence Award (K99\/R00). Her expertise is reflected in some 20 publications, numerous patents on antimicrobial therapeutics, and presentations given at national and international meetings.  During her keynote, she shared about the threat of multidrug-resistant Klebsiella pneumoniae and her team\u2019s discoveries regarding how antimicrobial peptides can overcome membrane-mediated colistin resistance. <\/p>\n\n\n\n

Dr. Fleeman\u2019s presentation was followed by these research talks:<\/p>\n\n\n\n